Author

Arpita Nag 1

1 Shire, a Takeda Company,Lexington,United States

Economic Evaluations of Biological Treatments for Moderate-to-Severe Crohn's Disease: Findings from a Systematic Literature Review

Molly Purser, Rikal Bhaila, Louise Hartley, Stephanie Earnshaw, Arpita Nag

ECONOMIC MODELS USED TO EVALUATE THE COST-EFFECTIVENESS OF BIOLOGIC TREATMENTS FOR ULCERATIVE COLITIS: A SYSTEMATIC LITERATURE REVIEW

Molly Purser, Louise Hartley, Stephanie Earnshaw, Rikal Bhaila, Arpita Nag

PHYSICIAN PREFERENCES FOR BIOLOGICS FOR THE TREATMENT OF CROHN'S DISEASE AND ULCERATIVE COLITIS IN FRANCE, GERMANY AND THE UNITED KINGDOM

Lynn Huynh, Steve Hass, Laurent Peyrin-Biroulet, Mei Sheng Duh, Heather Sipsma, Mu Cheng, Angela Lax, Arpita Nag

SYMPTOM AND QUALITY OF LIFE BURDEN AMONG PATIENTS WITH EOSINOPHILIC OESOPHAGITIS IN A REAL-WORLD SETTING

Alain M. Schoepfer, Stevie Olsen, Siddhesh Kamat, Urvi Mujumdar, Arpita Nag, Benjamin Ortiz, Juby A. Jacob-Nara, angela khodzhayev, Eilish McCann, Ledia Goga

SYSTEMATIC LITERATURE REVIEW TO ASSESS THE HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH ULCERATIVE COLITIS IN ADULTS IN EUROPE

Molly Purser, Louise Hartley, Stephanie Earnshaw, Rikal Bhaila, Arpita Nag

The Economic Burden of Crohn's disease in Europe: Findings from a systematic Literature Review

Molly Purser, Rikal Bhaila, Louise Hartley, Stephanie Earnshaw, Arpita Nag

TREATMENT PATTERNS AMONG PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE RECEIVING BIOLOGIC THERAPY IN FRANCE, GERMANY AND THE UNITED KINGDOM

Lynn Huynh, Steve Hass, Laurent Peyrin-Biroulet, Mei Sheng Duh, Heather Sipsma, Mu Cheng, Angela Lax, Arpita Nag

Item 1 - 7 / 7
1